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Cardiac stem/progenitor cells hold great potential for
regenerative therapies; however, the mechanisms
regulating their expansion and differentiation remain
insufficiently defined. Here we show that Ldb1 is a
central regulator of genome organization in cardiac
progenitor cells, which is crucial for cardiac lineage
differentiation and heart development. We demon-
strate that Ldb1 binds to the key regulator of cardiac
progenitors, Isl1, and protects it from degradation.
Furthermore, the Isl1/Ldb1 complex promotes long-
range enhancer-promoter interactions at the loci of
the core cardiac transcription factors Mef2c and
Hand2. Chromosome conformation capture followed
by sequencing identified specific Ldb1-mediated
interactions of the Isl1/Ldb1 responsive Mef2c ante-
rior heart field enhancer with genes that play key
roles in cardiac progenitor cell function and cardio-
vascular development. Importantly, the expression
of these geneswas downregulated upon Ldb1 deple-
tion and Isl1/Ldb1 haplodeficiency. In conclusion,
the Isl1/Ldb1 complex orchestrates a network
for heart-specific transcriptional regulation and coor-
dination in three-dimensional space during cardio-
genesis.
INTRODUCTION
Heart failure is the leading cause of morbidity and mortality
worldwide. A number of cardiac regenerative strategies have
been proposed, among which stem/progenitor cells hold great
promise for heart repair (Aguirre et al., 2013; Hansson et al.,
2009). Knowledge accumulated from developmental studiesCell Shas significantly improved the methods for in vitro cardiac differ-
entiation of embryonic stem cells (ESCs) and studies utilizing
ESC differentiation have brought further insights into the regula-
tory networks that integrate multiple transcription factors and
signaling molecules and strictly control the distinct steps of car-
diogenesis. However, the current limitations for the use of stem/
progenitor cells in regenerative medicine, e.g., those linked to
their expansion, differentiation efficiency, and functional integra-
tion, call for a more complete understanding of the mechanisms
driving cardiovascular lineage commitment and differentiation.
During embryogenesis the heart is generated by a common
progenitor at gastrulation that segregates into two distinct pop-
ulations, termed first and second heart fields. The first heart field
(FHF) fuses at the midline and differentiates into the myocardium
of the heart tube. After the initial heart tube formation, the heart
tube grows by the addition of Isl1-positive second heart field
(SHF) progenitor cells to its anterior and venous poles (Cai
et al., 2003; Evans et al., 2010; Vincent and Buckingham,
2010). Studies in different model systems revealed the crucial
function of the LIM-homeodomain (LIM-HD) transcription factor
Isl1 in heart morphogenesis (Cai et al., 2003; de Pater et al.,
2009; Witzel et al., 2012). Isl1-deficient mouse embryos lack
the right ventricle and the outflow tract, both structures derived
from the SHF, as Isl1 is required for the proliferation, survival,
and migration of these cells into the forming heart (Cai et al.,
2003). Importantly, the Isl1-positive cardiovascular progenitors
are multipotent and can differentiate into all three cardiovascular
lineages: cardiomyocytes, smooth muscle cells, and endothelial
cells (Moretti et al., 2006). Moreover, Isl1 is required for the differ-
entiation of these cells into the cardiomyocyte and smooth mus-
cle lineage (Kwon et al., 2009), but themechanisms underlying its
function are poorly understood.
The acquisition of cellular identity involves genome reorgani-
zation and a coordinated series of large-scale transcriptional
changes (Dixon et al., 2015; Gorkin et al., 2014; Peric-Hupkes
et al., 2010). Studies using chromosome conformation capture
(3C) assays and 3C-based technologies (de Wit and de Laat,tem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Inc. 287
2012; Dekker et al., 2002) have suggested that CTCF together
with Cohesinmight be involved in general formation of chromatin
structures by promoting constitutive long-range DNA interac-
tions, whereas specific transcription factors and their cofactors
together with CTCF, Cohesin, and the Mediator complex might
be involved in controlling locus-specific looping interactions
and lineage-specific transcription (Kagey et al., 2010; Phillips-
Cremins et al., 2013; Shen et al., 2012). In ESCs for example,
the binding of the key pluripotency transcription factors Oct4,
Sox2, and Nanog was shown to be a key determinant of genome
organization, as regions with a high density of binding sites for
these factors tend to colocalize in nuclear space (de Wit et al.,
2013; Denholtz et al., 2013). Another example for a cofactor
involved in promoting locus-specific and cell-type-specific inter-
actions is LIM-domain-binding protein 1 (Ldb1) (Deng et al.,
2012; Morcillo et al., 1997; Soler et al., 2010; Song et al.,
2007). Ldb1 directly binds to LIM domain proteins and Otx
proteins and is found in large complexes with bHLH and GATA
transcription factors (Bach et al., 1997; Meier et al., 2006; Tripic
et al., 2009). By bringing together distinct transcription factors
and their co-regulators that are associated with different
transcriptional control elements, Ldb1 facilitates long-range
enhancer-promoter interactions and regulates cell-type-specific
expression patterns (Deng et al., 2012; Soler et al., 2010; Song
et al., 2007).
Here we show that Ldb1 is a multifunctional regulator of car-
diac progenitor cell differentiation and SHF development. On
the one hand, Ldb1 binds to Isl1 and protects it from proteaso-
mal degradation, which leads to an almost complete loss of
Isl1+ cardiovascular progenitor cells upon Ldb1 deficiency. On
the other hand, the Isl1/Ldb1 complex plays a central role in
transcriptional regulation and chromatin organization in three-
dimensional space, driving cardiac progenitor cell differentiation
and SHF development.
RESULTS
Ldb1 Regulates Cardiac Progenitor Cell Differentiation
and SHF Development
The LIM domain transcription factor Isl1 is required for prolifera-
tion, survival, and differentiation of SHF cardiac progenitor cells
(Cai et al., 2003). The cofactor Ldb1 regulates spatial chromatin
organization and Ldb1 deficiency results in early embryonic
lethality with a series of developmental defects, including lack
of heart formation (Mukhopadhyay et al., 2003; Mylona et al.,
2013). Since Ldb1 is broadly expressed, it is attractive to spec-
ulate that via its diverse DNA binding partners, it mediates
distinct long-range interactions, leading to cell-type-specific
transcriptional programs. Therefore, we reasoned that Isl1 and
Ldb1 might work in concert to regulate cardiac progenitor cell
function. To elucidate the role of Ldb1 in cardiogenesis, we first
utilized WT and Ldb1 knockout (Ldb1/) ESCs and differenti-
ated them in embryoid bodies (EBs) to facilitate the generation
and differentiation of cardiac progenitors (Figure 1A). Impor-
tantly, in contrast to control EBs, which started beating already
at day 6 (d6), the EBs differentiated from Ldb1/ cells showed
no beating (Figure 1B). Consistent with this, the expression of
cardiomyocyte marker genes was dramatically reduced (Fig-
ure 1C). Additionally, the expression of endothelial markers288 Cell Stem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Iwas also downregulated, whereas the expression of smooth
muscle genes was upregulated (Figure 1C), suggesting that
Ldb1 is important for proper differentiation into cardiomyocyte
and endothelial cell lineages. Next, we analyzed whether Ldb1
deficiency affects early developmental decisions, e.g., meso-
derm induction, which could subsequently affect cardiac pro-
genitor cell differentiation. Real-time PCR analysis for mesoderm
markers (Eomes and Bry) and cardiac mesoderm markers
(Mesp1 and Mesp2) showed no significant difference in the
peak expression level between control and Ldb1-deficient
EBs; however, the peak expression of these markers was de-
layed by one day (Figure 1D). Next, we analyzed the expression
of pan-cardiac genes and genes specifically expressed in the
FHF and the SHF (Figure 1E). Interestingly, while the expression
of Isl1, Tbx1,Hand2, and Fgf10, which play important roles in the
SHF, and the pan-cardiac genes Nkx2-5 and Mef2c was signifi-
cantly downregulated at d4, d5, and d6, genes expressed in the
FHF (Tbx5, Hand1, and Gata4) showed no significant change
(Figure 1E, data not shown), suggesting a role of Ldb1 in the
regulation of SHF progenitor cells. To further investigate the
role of Ldb1 in SHF development, we ablated Ldb1 using an
Isl1-Cre driver line that results in Cre recombination in SHF
progenitor cells (Cai et al., 2003). Isl1-Cre:Ldb1flox/flox embryos
died by E10.5 with shortened outflow tract and small right
ventricle (Figures 1F–1G, Figure S1A). Furthermore, we observed
significant downregulation of cardiomyocyte marker genes in
the right ventricle and the outflow tract, both SHF-derived
structures, whereas no change in these genes was observed in
the left ventricle, derived mainly from the FHF (Figure 1H, Fig-
ure S1B). Taken together, these results confirm that Ldb1 is
essential for cardiac progenitor cell differentiation and SHF
development.
Ldb1 Loss Does Not Affect Early Cardiovascular
Progenitor Cell Commitment but Leads to a Compete
Loss of Isl1+ Cells
To gain a better understanding of Ldb1 function in cardiogene-
sis, we analyzed cardiovascular progenitors in more detail.
FACS analysis for Flk-1 and PdgfR-a demonstrated no signifi-
cant differences in early cardiovascular progenitor numbers (Fig-
ure 2A). Interestingly, although Isl1 mRNA levels were only
slightly reduced in EBs differentiated from Ldb1/ ESCs (Fig-
ures 1E and 2B), Isl1+ cells were virtually absent in Ldb1/
EBs (Figure 2C). Western blot analysis confirmed the dramati-
cally reduced levels of Isl1 in Ldb1-deficient EBs (Figure 2D).
The absence of Isl1 protein, without pronounced changes of
Isl1 mRNA levels, suggested that Isl1 is regulated at the protein
level. Pulldown of Isl1 detected slower-migrating ubiquitinated
forms of Isl1 that were increased in the presence of the protea-
somal inhibitor MG-132, indicating that Isl1 is targeted for pro-
teasomal degradation (Figure 2E). To analyze this in more detail,
we transfected HEK293T cells with Isl1 deletion constructs lack-
ing the LIM1 and/or LIM2 domain and treated themwithMG-132.
The levels of the truncated proteins lacking LIM2 or containing
only the homeodomain were relatively unchanged, but the levels
of the Isl1 protein lacking LIM1 were significantly increased upon
MG-132 treatment, suggesting that LIM2 is subjected to ubiqui-
tination (Figure 2F). Next, we analyzed whether binding of Ldb1
to Isl1 might protect it from proteasomal degradation, similarlync.
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Figure 1. Ablation of Ldb1 Results in Defects in Cardiac Progenitor Cell Differentiation and SHF Development
(A) Schematic diagram of the experimental setup.
(B) Percentage of beating EBs in WT and Ldb1/ ESCs.
(C) Relative mRNA expression of cardiomyocyte (Mlc2a, Mlc2v, and Tnnt2), endothelial (Flk-1 and CD31), and smooth muscle (SM-actin, SM-22a) genes in d9
EBs differentiated from WT and Ldb1/ ESCs.
(D) Relative mRNA expression of mesodermal markers (Eomes, Bry,Mesp1, andMesp2) in EBs differentiated from control and Ldb1/ ESCs at different days.
(E) Relative mRNA expression of cardiac progenitor marker genes in d4 EBs differentiated from Ldb1+/+ and Ldb1/ ESCs.
(F) Gross appearance of control (Isl1cre/+/Ldb1+/flox) and Isl1cre/+/Ldb1flox/flox embryos at E10.5. Scale bars, 500 mm.
(G) Higher magnification of E9.5 embryos viewed from the right (left panels) and the front (right panels). Scale bars, 200 mm. OFT, outflow tract; RV, right ventricle;
LV, left ventricle.
(H) Relative mRNA expression analysis of Ldb1 and cardiomyocyte genes in dissected outflow tract and right ventricle of E9.25 WT and Isl1cre/+/Ldb1flox/flox
embryos. Data are mean ± SEMs, n = 3 for each genotype.
Data in (B)–(E) are mean ± SEMs, n = 3. *p < 0.05, **p < 0.01, ***p < 0.005. See also Figure S1.to Lhx3 (Gu¨ngo¨r et al., 2007). To assess this possibility we trans-
fected HEK293T cells with an Isl1 plasmid alone or together with
increasing amounts of Ldb1 or Ldb1 deletion constructs and
constant amounts of GFP, which served as a control for transfec-
tion efficiency (Figure 2G). Importantly, increasing levels of Ldb1
and truncated Ldb1 protein lacking the dimerization domain
(DN-Ldb1) led to a significant increase of Isl1 protein levels,
but did not change the levels of truncated Isl1 proteins lacking
either the LIM1 or LIM2 domain or harboring only the Isl1 home-
odomain (Figures 2G and 2H). Furthermore, a truncated Ldb1
protein lacking the LIM-interaction domain (LID) did not have
an effect on Isl1 protein levels (Figure 2G). Co-immunoprecipita-
tions (co-IPs) using Isl1 deletion constructs revealed a critical
role of the LIM1 domain of Isl1 in mediating the interaction withCell SLdb1 (Figure 2I), corroborating previous findings (Jurata et al.,
1996). Together, these data suggest that the binding of Ldb1
to the LIM1 domain of Isl1 protects it from ubiquitination at the
LIM2 domain and from subsequent proteasomal degradation
(Figure 7E).
Ldb1 and Isl1 Physically, Functionally, and Genetically
Interact to Regulate Cardiac Progenitor Cell
Differentiation and Heart Development
Ldb1 plays fundamental roles in development and cell differenti-
ation as a cofactor for LIM-domain proteins, suggesting that
Ldb1 and Isl1 might functionally interact with each other during
cardiogenesis. To test this, we first confirmed that Ldb1 and
Isl1 interact in cardiac progenitor cells expressing endogenoustem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Inc. 289
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Figure 2. Ldb1 Binds to Isl1 and Protects It
from Proteasomal Degradation
(A) FACS analysis of Flk-1 and PdgfR-a expression
in d3.75 EBs differentiated from control and
Ldb1/ ESCs.
(B) Relative mRNA expression of Isl1 in EBs
differentiated from control and Ldb1/ ESCs at
different days. Data are mean ± SEMs, n = 3. *p <
0.05, **p < 0.01.
(C) Isl1 immunostaining on vibratome sections
from d5 EBs differentiated from control and
Ldb1/ ESCs. Scale bars, 100 mm.
(D) Western blot analysis of total protein extracts of
day 4, 5, and 6 EBs differentiated from control and
Ldb1/ESCs. LaminB1 served as loading control.
(E) HA-tagged ubiquitin and Isl1 were transiently
expressed in HEK293T cells. Cells were either
treated with DMSO or with MG-132 6 hr before be-
ing harvested. Equivalent amounts of total cellular
protein were immunoprecipitated with an anti-Isl1
antibody and detected with an anti-HA antibody.
(F) Schematic representation of Isl1 and Isl1 dele-
tion constructs lacking either LIM1 or LIM2 or
harboring only the homeodomain (top). Western
blot analysis of whole-cell lysates of HEK293T cells
transfected with Isl1, Isl1DLIM1, Isl1DLIM2, and
Isl1Homeo expression plasmids, treated with
DMSO or MG-132 is shown.
(G) Schematic representation of Ldb1 and Ldb1
deletion constructs. Ldb1 harbors three domains
important for its function: dimerization domain (DD),
the Ldb1/Chip conserved domain (LLCD), and the
LIM-interaction domain (LID) (top panel). HEK293T
cells were transfectedwith constant amounts of Isl1
(10 mg) and GFP (1 mg, used as a control of
transfection efficiency) expression plasmids and
increasing amounts of Ldb1, Ldb1DLID, and DN-
Ldb1 (5 and 9 mg). Immunoblot analysis of equal
amounts of total protein extracts was performed
using either anti-Isl1 or anti-GFP antibodies.
(H) Western blot analysis of whole-cell lysates from
HEK293T cells transfected with Isl1, Isl1DLIM1,
Isl1DLIM2 and Isl1Homeo alone or together with
DN-Ldb1 and GFP using anti-Isl1, anti-FLAG, and
anti-GFP antibodies.
(I) FLAG-HA-Ldb1 and Isl1 or Isl1 deletion con-
structswere transiently expressed inHEK293Tcells
and immunoprecipitation with an anti-Isl1 antibody
was followed by immunoblot analysis with an anti-
FLAG antibody.levels of each protein by performing immunoprecipitation of
Ldb1 from nuclear extracts of d5 EBs, a stage enriched in car-
diac progenitors (Figure 3A). Next, we transfected mouse
ESCswith an expression plasmid carrying GFP alone or together
with Isl1, Ldb1, or both Isl1 and Ldb1 (Figures S2A and S2B).
GFP-expressing cells, isolated by FACS, were subjected to dif-
ferentiation in EBs. Overexpression of Isl1 or Ldb1 alone signifi-
cantly increased the percentage of beating EBs. Importantly,
EBs differentiated from Isl1/Ldb1-overexpressing cells showed
a higher number of beating foci compared to control EBs or
EBs overexpressing Isl1 or Ldb1 alone, which had similar levels
of Isl1 and Ldb1 compared to Isl1/Ldb1-overexpressing cells
(Figure 3B, Figures S2A and S2B). Consistently, the expression
of cardiomyocyte marker genes was markedly increased and290 Cell Stem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Iwe observed a significant synergistic effect of Isl1 and Ldb1 on
Mlc2a expression (Figure 3C). Furthermore, the expression of
endothelial and smooth muscle markers was also increased
(Figures 3D and 3E). Moreover, cardiac progenitor genes
(endogenous Isl1, Mef2c, Hand2, and Fgf10) were significantly
upregulated (Figure 3F). Interestingly, overexpression of Ldb1
significantly increased Flk-1+PdgfR-a+ cardiovascular progeni-
tor numbers and the expression of Flk-1 and PDGFR-a (Fig-
ure 3G, Figure S2C), which may account for the increased
expression of markers of all major cardiovascular lineages in
Ldb1 and Isl1/Ldb1-overexpressing cells. Finally, we tested
whether Isl1 and Ldb1 genetically interact during heart develop-
ment. Crossing of Isl1 heterozygous and Ldb1 heterozygous
mice revealed that only 5% of pups were compoundnc.
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Figure 3. Ldb1 and Isl1 Interact to Regulate Cardiogenesis
(A) Co-immunoprecipitation of nuclear extracts from d5 EBs using anti-Ldb1 antibody and detected with anti-Isl1 antibody.
(B) Percentage of beating d7 EBs derived from ESCs overexpressing either GFP alone (control) or GFP together with Isl1, Ldb1, or both.
(C–E) Relative mRNA expression of cardiomyocyte (C), endothelial (D), and smooth muscle marker genes (E) in d7 EBs differentiated from ESCs overexpressing
either GFP alone or GFP together with Isl1, Ldb1, or Ldb1+Isl1.
(F and G) Relative mRNA expression of cardiac progenitor marker genes in d4 EBs (F) and Flk-1 and PdgfR-a in d3.75 EBs (G) differentiated from ESCs over-
expressing either GFP alone or GFP together with Isl1, Ldb1, or Ldb1+Isl1. For qPCR analysis of endogenous Isl1 levels, primers located in the 50 UTR were
utilized.
(H–J) H&E staining of representative paraffin sections of E16.5 hearts of WT and Isl1+/Ldb1+/ embryos (H, top panels), and higher magnification of right and left
ventricles showing thinner compact myocardium of the right ventricle in Isl1+/Ldb1+/ embryos (H, bottom panels), DORV (I), or OA in E18.5 hearts (J) with VSD
(I and J). Ao, Aorta; PA, pulmonary artery; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle; DORV, double outlet right ventricle; OA, overriding
aorta; VSD, ventricular septal defect.
(K) Morphometric analysis of right ventricle compact myocardial thickness. Data are mean ± SEMs, n = 4.
(L) Relative mRNA expression analysis of cardiac progenitor and cardiomyocyte genes in dissected hearts and SHF of E9.25 WT, Isl1+/, Ldb1+/ (controls), and
Isl1+/Ldb1+/ embryos. Data are mean ± SEMs, n = 4 for each genotype. *p < 0.05, **p < 0.01, ***p < 0.005.
Data in (B)–(G) are mean ± SEMs, n = 3. *p < 0.05, **p < 0.01, ***p < 0.005. See also Figure S2.heterozygotes at the weaning stage, whereas an expected ratio
of 25%was observed during mid- to late gestation (Figure S2D),
suggesting that the compound heterozygotes die after birth. His-
tological analysis revealed that Isl1/Ldb1 double haplodeficient
embryos had various heart abnormalities, including a small and
thin right ventricle, ventricular septal defect (VSD), overriding
aorta (OA), and double outlet right ventricle (DORV) (Figures
3H–3K). To analyze the primary cause of the observed heart de-
fects we microdissected the heart and the SHF fromWT, Isl1+/,
Ldb1+/, and Isl1+/Ldb1+/ E9.25 embryos. Importantly, real-
time PCR analysis revealed significant downregulation of
Hand2, Mef2c, Fgf10, and Mlc2v expression in Isl1+/Ldb1+/,Cell Ssupporting a key role of the Isl1/Ldb1 complex in cardiomyocyte
differentiation and Mef2c, Hand2, and Fgf10 expression
(Figure 3L).
The Dimerization Domain of Ldb1 Is Required for SHF
Development and Cardiac Progenitor Cell
Differentiation
Next, we ectopically overexpressed a truncated form of
Ldb1 lacking the dimerization domain (DN-Ldb1, Figure 2G,
Figure S3A) in embryos of the zebrafish transgenic line
Tg(myl7:EGFP-HsHRAS)s883, which allows the easy monitoring
of cardiac morphology (D’Amico et al., 2007). DN-Ldb1 containstem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Inc. 291
the highly conserved LID and can stabilize Isl1 protein levels (Fig-
ures 2G and 2H), but lacks the dimerization domain necessary to
promote long-range enhancer-promoter interactions. Overex-
pression of this mutant DN-Ldb1 protein results in a competition
withWT Ldb-s for binding to LIM-HDproteins as it acts in a domi-
nant-negative manner (Bach et al., 1999; Becker et al., 2002).
Consistent with previous studies, overexpression of DN-Ldb1
led to defects in eye and brain development (Figure S3B; (Becker
et al., 2002)). Additionally, we observed that the heart contracted
irregularly and with a reduced frequency (Figures S3C and S3D)
in the embryos expressing DN-Ldb1. Furthermore the atrium of
DN-Ldb1-expressing embryos was significantly shorter (Fig-
ure S3E). A similar phenotype was observed in isl1mutant zebra-
fish embryos as a result of a failure of cardiomyocyte differenti-
ation at the venous pole (de Pater et al., 2009). Confocal
images of control and DN-Ldb1-expressing embryos stained
with anti-Isl1 antibodies at 48 hours post-fertilization (hpf) re-
vealed dramatically fewer Isl1+ cardiomyocytes at the venous
pole of the heart. In mutants, Isl1+ cells were found outside of
the heart, but did not express the cardiomyocyte marker myl7,
supporting a key role of Ldb1 dimerization in Isl1+ cardiomyo-
cyte differentiation (Figure 4A). Further, bmp4 expression at the
sinus venosus was strongly reduced in DN-Ldb1-expressing
embryos, in striking parallel to isl1 mutant embryos (Figure 4B).
Additionally, the expression of mef2cb was also downregulated
(Figure 4C). Next, we addressed whether this phenotype can be
attributed to defects at early stages of cardiogenesis by perform-
ing in situ hybridization and whole-mount anti-Isl1 immunostain-
ing of control and DN-Ldb1-overexpressing embryos at the 10
and 15 somites stage. No significant change of isl1 mRNA
expression was detected (Figure 4D). However, Isl1 staining ap-
peared to be stronger in the injected embryos, consistent with
the stabilizing effect of DN-Ldb1 on Isl1 protein levels (Figure 4D,
Figure 2). Importantly, we observed strong downregulation of
hand2, mef2cb, and nkx2-5, which play important roles in the
SHF development (Figure 4D), whereas no change was
observed in tbx5a expression. These findings suggest that not
only the stabilization of Isl1 protein levels but also the formation
of higher-order complexes mediated by the Ldb1 dimerization
domain might be important for proper cardiac progenitor cell dif-
ferentiation during SHF development. To gain further support of
this hypothesis, we generated stable Ldb1-deficient ESC lines
overexpressing GFP alone, Isl1, Ldb1, DN-Ldb1, or these in
combinations. Consistent with an important role of Ldb1 in regu-
lating Isl1 stability, Isl1-overexpressing Ldb1/ ESCs showed
dramatically lower Isl1 protein levels compared to Ldb1/
ESCs overexpressing Isl1 in combination with Ldb1 or the DN-
Ldb1 (Figure S4A), although Isl1 mRNA levels were similar (Fig-
ure S4B). Importantly, Ldb1 overexpression led to a rescue of
cardiac differentiation, as measured by the increased percent-
age of beating EBs and mRNA levels of cardiomyocyte marker
genes (Figures 4E and 4F). The functional rescue was further
potentiated by overexpression of Isl1, confirming a synergistic
role of these proteins in cardiomyocyte differentiation. By
contrast, overexpression of DN-Ldb1 alone or in combination
with Isl1 did not rescue the complete loss of cardiac differentia-
tion of Ldb1-deficient EBs (Figures 4E and 4F). Furthermore, the
expression of endothelial marker genes was increased in
Ldb1/ EBs overexpressing Ldb1, whereas smooth muscle292 Cell Stem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Igeneswere decreased by Ldb1 overexpression (Figure 4G), sup-
porting a role of Ldb1 in the differentiation of cardiovascular pro-
genitors into the cardiomyocyte and endothelial cell lineages and
suppression of the smooth muscle lineage. FACS analysis for
Flk-1 and PdgfR-a showed no significant differences in the
Flk-1+PdgfR-a+ cardiovascular progenitor numbers upon Ldb1
and Isl1/Ldb1 overexpression in Ldb1-deficient EBs (Figure 4H),
demonstrating that the dramatically increased cardiac differenti-
ation is not due to an increased induction of cardiovascular pro-
genitor cells. However, we observed a pronounced decrease of
the Flk-1+/PdgfR-a+ population upon DN-Ldb1 expression (Fig-
ure 4H). Interestingly this decrease was rescued by Isl1 overex-
pression in combination with DN-Ldb1 (Figure 4H), suggesting
that the decrease in cardiovascular progenitor cells upon DN-
Ldb1 overexpression might be due to interference with the func-
tion of LIM only or LIM-HD proteins. Furthermore, we saw rescue
of Isl1+ cells and Isl1 expression upon Ldb1 and DN-Ldb1
expression (Figure 4I, Figure S4C), consistent with the role of
Ldb1 and DN-Ldb1 in stabilizing Isl1 protein levels, suggesting
that the inability of DN-Ldb1 to rescue the cardiac differentiation
defects of the Ldb1-deficient cells is not due to lack of Isl1+ cells.
Importantly, the expression ofMef2c and Hand2, factors crucial
for SHF development and differentiation, was significantly upre-
gulated upon Ldb1 overexpression, but not upon overexpres-
sion of DN-Ldb1 (Figure 4J). Isl1 has been shown to directly
bind to the anterior heart field (AHF) enhancer, which directs
the expression of Mef2c in the AHF (Dodou et al., 2004, Witzel
et al., 2012). Additionally, we found several conserved Isl1
consensusmotifs (YTAATGR; TAAKKR;Mazzoni et al., 2013) be-
tween 1.5 kb and theMef2c transcription start site (Figure S5).
Chromatin immunoprecipitation (ChIP) analysis of nuclear ex-
tracts from d5 EBs and pools of E8–9 embryos demonstrated
specific binding of Isl1 and Ldb1 to the conserved Isl1 binding
sites (Figures 4K and 4L). Additionally, we found Hand2 expres-
sion to be significantly altered upon loss and gain of function of
Ldb1. Hand2 plays a key role in SHF development (Srivastava
et al., 1997), and its expression in the heart is specifically driven
by a cardiac-specific enhancer located between 4.5 kb and
2.7 kb of the Hand2 transcription start site (Figure S6; OFTRV
enhancer) (McFadden et al., 2000). In silico analysis revealed
several Isl1 consensus binding sites in the proximal promoter
and the OFTRV enhancer of Hand2 (Figure S6). ChIP analysis
of d5 EBs and E8–9 embryos showed strong binding of both
Isl1 and Ldb1 at these sites (Figures 4M and 4N). Taken together,
our data indicate thatMef2c and Hand2 are direct targets of the
Isl1/Ldb1 transcriptional complex.
Ldb1 Facilitates Enhancer-Promoter Interactions within
the Hand2 and Mef2c Loci
Ldb1 promotes chromatin looping events that bring distal en-
hancers into close proximity to promoters, thereby regulating
gene expression (Deng et al., 2012; Soler et al., 2010; Song
et al., 2007). To assess whether a similar mechanism controls
cardiac progenitor cell gene expression, we analyzed whether
binding of the Isl1/Ldb1 complex promotes chromatin loop for-
mation at the relatively small Hand2 locus. Using 3C-qPCR anal-
ysis with the Hand2 promoter as a viewpoint, we observed a
specific close proximity of the promoter with the OFTRV
enhancer in d5 EBs from WT ESCs, but not in d5 EBs fromnc.
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Figure 4. The Dimerization Domain of Ldb1 Is Required for Cardiomyocyte Differentiation
(A) Confocal images of control and DN-Ldb1-overexpressing Tg(myl7:EGFP-HsHRAS)s883 zebrafish embryos at 48 hr post fertilization (hpf) stained with anti-GFP
and anti-Isl1 (red) antibodies. Arrows indicate Isl1+ cells outside of the heart, which do not express the cardiomyocyte marker myl7. Scale bars, 50 mm.
(B and C) In situ hybridization of control, DN-Ldb1-overexpressing, and isl1mutant embryos at 48 hpf with bmp4 (B) andmef2cb (C) probes. The arrows indicate
bmp4 expression at the sinus venosus.
(D) Confocal images of control and DN-Ldb1-overexpressing embryos stained with anti-Isl1 antibody (leftmost panels) and in situ hybridization of control and DN-
Ldb1-overexpressing embryos at 10–15 somite stages with isl1, nkx2.5, hand2, tbx5a, and mef2cb probes.
(E) Percentage of beating d7 EBs derived from Ldb1/ ESCs overexpressing either GFP alone (control) or GFP together with Isl1, Ldb1, DN-Ldb1, or these in
different combinations.
(F and G) Relative mRNA expression analysis of cardiomyocyte (F), smooth muscle, and endothelial marker (G) genes in d7 EBs.
(H) FACS analysis of Flk-1 and PdgfR-a expression in d3.75 Ldb1/ EBs overexpressing either GFP alone or GFP together with Isl1, Ldb1, DN-Ldb1, or these in
different combinations.
(I) Western blot analysis of total protein extracts of d5 EBs.
(J) Relative mRNA expression of Mef2c and Hand2 in d4 EBs.
(K and L) ChIP of nuclear extracts from d5 EBs (K) and pools of dissected SHF from E8–9 embryos (L) using anti-Isl1 and anti-Ldb1 antibodies or IgG as control.
PCRs were performed using primers flanking conserved Isl1 binding sites in the Mef2c promoter and the AHF enhancer. Fold enrichment values for EBs were
calculated relative to IgG control and for embryos relative to a genomic region that does not contain conserved Isl1 binding sites. Data are mean ± SEMs, n = 3.
(M andN) ChIP of nuclear extracts from d5EBs (M) and pools of dissected SHF from E8–9 embryos (N) using anti-Isl1 and anti-Ldb1 antibodies or IgG as a control.
Data are mean ± SEMs, n = 3.
Data in (E)–(G) and (J) are mean ± SEMs, n = 3. *p < 0.05, **p < 0.01, ***p < 0.005. See also Figures S3–S7.Ldb1-deficient cells (Figure 5A). A similar interaction pattern was
observed in Ldb1/ EBs overexpressing Ldb1 and Isl1/Ldb1,
but not in EBs overexpressing DN-Ldb1 or Isl1/DN-Ldb1 (Fig-
ure 5A, Figure S7A). No interaction was observed between the
promoter and negative regions for Isl1 and Ldb1 binding.
Further, no interaction was detected in WT and Ldb1-deficient
ESCs, which do not express Isl1 (Figure 5A, Figure S7A).Cell SWe next performed 3C-seq (Stadhouders et al., 2013) to char-
acterize the spatial interactions within theMef2c locus using two
viewpoints: the Mef2c AHF enhancer, which drives Mef2c
expression specifically in the AHF, and the Mef2c promoter,
which drives Mef2c expression in different cell types. Multiple
promoter-interacting elements were detected in the Mef2c lo-
cus, of which some showed a lower signal in Ldb1-deficienttem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Inc. 293
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Figure 5. Ldb1 Facilitates Enhancer-Promoter Interactions within the Hand2 and Mef2c Loci
(A) Schematic representation of the Hand2 genomic locus and the position of the DpnII restriction sites used in the 3C assay (top). 3C-qPCR relative crosslinking
frequency in WT, Ldb1/ ESCs, WT and Ldb1/ ESCs, or d5 EBs derived from Ldb1/ ESCs overexpressing either GFP alone or GFP together with Isl1, Ldb1,
DN-Ldb1, or these in different combinations is shown. TheHand2 promoter was used as the viewpoint. Values were normalized to the b-actin locus and the value
for the OFTRV enhancer in d5 WT EBs was set as one. Data are mean ± SEMs, n = 3.
(B) Schematic representation of theMef2c genomic locus and the position of the restriction sites of HindIII, used in the 3C assay (top). 3C-seq analysis ofMef2c
AHF- (middle panel) andMef2c promoter-associated regions (bottom panel) in d5 WT and Ldb1/ EBs is shown. The viewpoint is indicated with an eye symbol.
Only statistically significant interactions identified by the r3Cseq package (Thongjuea et al., 2013) are presented (p < 0.05).
(C) 3C-qPCR relative crosslinking frequency in EBs at different days (top panel) and in microdissected SHF region, heart, brain, or tail from embryos at different
developmental stages (bottom panel). Data are mean ± SEMs, n = 3.
(D) 3C-qPCR relative crosslinking frequency observed in d4 (top) and d5 (bottom) EBs derived from WT and Ldb1/ ESCs or Ldb1/ ESCs overexpressing
either GFP alone or GFP together with Isl1, Ldb1, and DN-Ldb1 in different combinations. Data are mean ± SEMs, n = 3. For the 3C-qPCR in (C) and (D) the HindIII
fragment containing the Mef2c-AHF was used as the viewpoint (red bar, eye symbol).
(E) Schematic representation of alternativeMef2c transcripts (top) and absolute quantification of these transcripts using primers indicated in the scheme (bottom).
(F) ChIP of d4 EBs derived from WT and Ldb1/ ESCs using antibodies against H3, H3K4me1, H3K27Ac, p300, RNA-PolIIS5p, and IgG as a control. Data are
mean ± SEMs, n = 3. *p < 0.05, **p < 0.01, ***p < 0.005. See also Figure S7.EBs (Figure 5B). Importantly, we observed interactions of the
AHF enhancer with the promoter area and with the 30 end of
the Mef2c gene, which were decreased in Ldb1-deficient EBs
(Figure 5B). 3C-qPCR experiments revealed a similar long-range
interaction pattern in WT versus Ldb1/ EBs during the course
of cardiac differentiation and in dissected SHF and hearts of E8–
10.5 embryos, confirming the 3C-seq results (Figure 5C). Inter-
estingly, we observed interactions of the AHF enhancer with
the Mef2c proximal promoter co-occupied by Isl1 and Ldb1 in
d4 EBs at the onset of Mef2c expression and in dissected SHF
of E8.5 embryos, whereas in d5 EBs and hearts from E9.5–294 Cell Stem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier I10.5 embryos, we observed strong interactions with regions
more distal to the transcription start site (Figures 5C and 5D).
Additionally, no interactions of the AHF enhancer with the pro-
moter and with the 30 end of the Mef2c gene were observed in
tail and brain, suggesting that these chromatin loops are specif-
ically formed in cardiac progenitor cells. Importantly, the 3C
results correlated with the binding of Isl1 and Ldb1 at the
Mef2c locus (Figure S7B). Next, we analyzed whether Ldb1
dimerization is required for chromatin loop formation by perform-
ing 3C-qPCR in d4 and d5 EBs from Ldb1/ ESCs overexpress-
ing Isl1, Ldb1, and DN-Ldb1 alone or in combinations. Using thenc.
AHF enhancer as a viewpoint, we observed a specific interaction
of the AHF enhancer with the Mef2c promoter and the 30 end of
the Mef2c gene in Ldb1/ EBs overexpressing Ldb1 and Isl1/
Ldb1, but we observed no interaction of these genomic regions
in Ldb1/ EBs overexpressing DN-Ldb1 and Isl1/DN-Ldb1 (Fig-
ure 5D). To analyze whether the inability of DN-Ldb1 to promote
loop formation was due to its inability to bind to the Isl1/Ldb1
binding sites, we performedChIP of Ldb1/ ESCs overexpress-
ing Isl1 alone or in combinations with HA-Ldb1 or HA-DN-Ldb1
using anti-HA antibody. Importantly, we observed similar enrich-
ment of Ldb1 and DN-Ldb1 at the Mef2c promoter and AHF
enhancer (Figure S7C). Thus, the DN-Ldb1/Isl1 complex binds
at its target sites, but it cannot promote long-range enhancer-
promoter interactions necessary for gene expression. Finally,
luciferase assays revealed a significant synergistic effect of Isl1
and Ldb1 on a luciferase construct containing the Mef2c pro-
moter upstream and the Mef2c AHF enhancer downstream of
a luciferase gene, compared to a reporter construct harboring
the Mef2c promoter alone (Figure S7D), suggesting that Isl1/
Ldb1 complexes are required for enhancer-promoter interac-
tions to ensure high levels of Mef2c expression.
To understand the functional significance of the dynamic chro-
matin looping at theMef2c locus, we analyzed the expression of
annotated alternative Mef2c transcripts. Interestingly, while the
longer reference sequence transcript (NM_001170537) was
highly expressed in d4 EBs and in dissected SHF, the transcript
with the alternative transcriptional start site (TSS) 1.5 kb down-
stream of the AHF enhancer was more abundant later during
EB differentiation and in dissected hearts (Figure 5E), implying
that the observed dynamic chromatin looping correlates with
the expression of alternative transcripts for Mef2c. To better
characterize the –14 kb to –5.5 kb genomic region found in close
proximity to the AHF enhancer, we screened this region for
known enhancer-associated chromatin marks H3K27ac,
H3K4me1, p300, and Pol II. We found a marked enrichment of
these marks 13 kb upstream of the TSS, which correlated
with strong binding of Isl1 and Ldb1 at these sites (Figure 5F, Fig-
ure S7B). Sites within the –14 kb to –5.5 kb genomic region that
were not bound by Isl1 and Ldb1 did not show significant enrich-
ment of enhancer-associated chromatin marks (Figure 5F).
Ldb1 Orchestrates a Network for Transcriptional
Regulation and Coordination in Three-Dimensional
Space during Cardiogenesis
Gene Ontology (GO) analysis of sequences found by the 3C-seq
in close proximity to the AHF enhancer over-represented in WT
versus Ldb1/ EBs showed an enrichment of genes involved
in heart and cardiac muscle development, cell fate commitment,
and vasculature development within the first ten most enriched
GO terms (Figure 6A, p < 0.01). By contrast, a similar analysis us-
ing the sequences found in proximity to the Mef2c promoter
showed no overrepresentation of GO terms involved in heart
development (Figure 6B). Importantly, we found that the AHF
enhancer is involved in contacts with multiple genes that play
key roles during cardiac progenitor cell differentiation and heart
development (Figure 6C, Table S1). 3C-qPCR analysis of WT
versus Ldb1/ EBs, as well as of dissected SHF or tails of
E8–9 embryos, confirmed the specificity and the Ldb1 depen-
dence of these interactions (Figures 6D and 6E). Importantly, inCell SLdb1-deficient EBs we observed significant downregulation of
selected genes that show higher association with the AHF
enhancer in WT versus Ldb1/ EBs (Figure 7A). By contrast,
genes showing similar association with the AHF enhancer in
WT and Ldb1/ EBs (Rai2 and Xrcc4) were not altered. Further-
more, overexpression of Ldb1 or Ldb1 with Isl1, but not DN-
Ldb1, strongly promoted the expression of the genes that were
highly associated with the AHF enhancer in wild-type EBs (Fig-
ure 7B). Moreover, we observed significant downregulation of
these genes in hearts and dissected SHF regions of Isl1+/
Ldb1+/ E9.25 embryos compared to WT embryos (Figures 7C
and 7D). Taken together, these data provide strong evidence
that the Isl1/Ldb1-containing transcription complexes orches-
trate a network of transcriptional regulation and coordination in
three-dimensional space to regulate cardiac progenitor cell dif-
ferentiation and heart development (Figure 7E).
DISCUSSION
The differentiation of cardiac progenitor cells into distinct line-
ages involves a coordinated series of large-scale transcriptional
changes, but how these events are coordinated at the molecular
level has remained poorly understood. Our study shows that a
complex between the central SHF transcription factor Isl1 and
the multi-adaptor protein Ldb1 plays a crucial role in directing
chromatin organization and coordinating a cardiac-lineage-spe-
cific gene expression program.
We show that Ldb1-deficiency results in a markedly
decreased expression of SHF marker genes and subsequently
impaired differentiation into the cardiomyocyte and endothelial
lineages, while differentiation into the smooth muscle lineage
was increased. Ldb1 gain-of-function experiments confirmed
the requirement of Ldb1 in the differentiation of cardiovascular
progenitors in cardiomyocytes and endothelial cells and in the
suppression of the smooth muscle lineage. FACS analysis for
Flk-1 and PdgfR-a revealed no significant differences in cardio-
vascular progenitor numbers upon Ldb1 deficiency, showing
that Ldb1 loss affects the differentiation of cardiovascular pro-
genitor cells, but not cardiogenic lineage commitment. Interest-
ingly, overexpression of Ldb1 in WT EBs significantly increased
the number of Flk-1+PdgfR-a+ cardiovascular progenitors, sug-
gesting that modulation of Ldb1 levels might affect cardiac line-
age commitment. Consistent with this, competition of full-length
Ldb-s for binding to LIM-domain proteins by DN-Ldb1 led to a
significant decrease in Flk-1+PdgfR-a+ cardiovascular progeni-
tor cells, implying functional redundancy between Ldb1 and
Ldb2 in cardiac lineage commitment. We show that the require-
ment of Ldb1 for cardiac progenitor cell differentiation and SHF
development is two-fold (Figure 7E): (1) Ldb1 binds to Isl1 and
protects it from proteasomal degradation, as a consequence
of which Ldb1 deficiency leads to an almost complete loss of
Isl1+ cardiovascular progenitor cells. We show that Isl1 is ubiq-
uitinated at its LIM2 domain and that Ldb1 protects Isl1 from
degradation mainly via binding to the Isl1 LIM1 domain. This is
consistent with previous studies showing that LIM-HD protein
levels are regulated by the proteasome and that binding of
Ldb1 to LIM domain proteins protects them from degradation
(Gu¨ngo¨r et al., 2007). (2) The Isl1/Ldb1 complex orchestrates
a network for transcriptional regulation and coordination intem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Inc. 295
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Figure 6. Ldb1 Promotes Chromatin Looping between the AHF Enhancer and Genes That Play Key Roles in Cardiovascular Development
(A and B) Gene ontology analysis of genes interacting with the Mef2c AHF (A) or the Mef2c promoter (B), overrepresented in WT versus Ldb1/ cells.
(C) Schematic representation of 3C-seq results showing specific interactions of theMef2c AHFwith genes that play key roles in cardiovascular development. The
HindIII restriction sites are shown as black bars. y axes: reads per million.
(D and E) 3C-qPCR validation of the interactions observed using the 3C-seq approach in WT or Ldb1/ d5 EBs (D) or in microdissected SHF regions and tails of
E8–9 embryos (E) using the Mef2c-AHF as viewpoint. Data are mean ± SEMs, n = 3. *p < 0.05, **p < 0.01, ***p < 0.005.three-dimensional space in cardiac progenitors, driving cardiac
progenitor cell differentiation and heart development. Consis-
tent with this, a truncated Ldb1 protein (DN-Ldb1), which pro-
tects Isl1 protein from degradation, but cannot promote long-
range enhancer-promoter interactions (Krivega et al., 2014),
did not collaborate with Isl1 to regulate the expression of their
common targets and failed to rescue the cardiac differentiation
defects of Ldb1-deficient cells (Figures 4E and 4F). Importantly,
overexpression of DN-Ldb1 in zebrafish embryos leads to de-
fects in the differentiation of Isl1+ cardiac progenitors in striking
parallel with isl1 mutant fishes (de Pater et al., 2009), presum-
ably by competing with full-length Ldb1 for binding to Isl1
(Bach et al., 1999). Further, overexpression of DN-Ldb1 caused
significant downregulation of hand2 and mef2cb, transcription
factors that play important roles in cardiomyocyte differentiation
and heart development (Lin et al., 1997; Srivastava et al., 1997).
Similarly, we observed decreased expression of Hand2 and
Mef2c in Ldb1-deficient EBs, which showed complete blockade
of cardiomyocyte differentiation, and in Isl1/Ldb1 haplodeficient
embryos, which developed various cardiac anomalies. Our re-
sults also show that the Isl1/Ldb1 complex directly regulates
Mef2c and Hand2 expression by binding to their heart-specific
enhancers and stimulating enhancer-promoter interactions.
Similarly, Ldb1 is required for the looping of the b-globin locus296 Cell Stem Cell 17, 287–299, September 3, 2015 ª2015 Elsevier Icontrol region (LCR) to the b-globin promoter and transcrip-
tional activation (Deng et al., 2012; Krivega et al., 2014; Soler
et al., 2010; Song et al., 2007). 3C-seq and 3C-qPCR using
the Isl1- and GATA-responsive AHF enhancer of Mef2c (Dodou
et al., 2004) as a viewpoint showed close proximity of the pro-
moter region, the AHF enhancer, and the 30 end of the gene.
Gene looping has been shown to bring promoter and terminator
regions in close proximity in the early stages of transcriptional
activation, facilitating RNA Pol II re-initiation and high-level
expression of the long genes FMP27 and SEN1 in Saccharo-
myces cerevisiae (O’Sullivan et al., 2004). Similarly, the
observed loop between the promoter and the 30 end of the
Mef2c gene could generate a functional re-initiation complex
for subsequent rounds of Mef2c transcription. In addition we
observed dynamic chromatin looping at the Mef2c locus during
heart development and in the course of cardiac progenitor cell
differentiation. The AHF enhancer contacts the proximal pro-
moter during the onset of Mef2c gene activation in the AHF,
whereas later this contact is lost, correlating with the expression
of an alternative transcript with a TSS 1.5 kb downstream of the
AHF enhancer. A similar developmental switch in chromatin
looping was observed during erythroid differentiation at the
b-globin locus, from favoring the expression of embryonic
globin genes in erythroid progenitors to favoring the expressionnc.
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Figure 7. The Isl1/Ldb1 Complex Orches-
trates a Network for Transcriptional Regula-
tion and Coordination in Three-Dimensional
Space, Driving Cardiogenesis
(A) Relative mRNA expression analysis in d4 and d6
WT and Ldb1/ EBs of selected genes identified in
the 3C-seq analysis to specifically interact with the
Mef2c-AHF in WT, but not in Ldb1/ EBs.
(B) Relative mRNA expression analysis of selected
genes in d5 Ldb1/ EBs overexpressing either GFP
alone or GFP together with Isl1, Ldb1, DN-Ldb1, or
these in different combinations.
(C and D) Relative mRNA expression analysis of
selected genes in SHF (C) or heart (D) of WT or Isl1+/
Ldb1+/ E9.25 embryos. Data are shown as mean ±
SEMs, n = 4. *p < 0.05, **p < 0.01, ***p < 0.005.
(E) Model of the role of Ldb1 in cardiac lineage dif-
ferentiation. Ldb1 binds to Isl1 and protects it from
proteasomal degradation. The stabilized Isl1/Ldb1
complex orchestrates a network for transcriptional
regulation and coordination in three-dimensional
space, driving cardiac progenitor cell differentiation
and heart development.of the adult globin genes in definitive erythrocytes (Palstra et al.,
2003).
Remarkably, our 3C analysis identified specific, Ldb1-medi-
ated interactions of the AHF enhancer with multiple genes that
play key roles in cardiovascular development as well as cell
fate commitment. This could be due to these genes being in close
proximity in the same transcription factory, or Ldb1may be regu-
lating a cardiac-specific interaction network around the Mef2c
AHF enhancer. The interactions are cell type specific, as they
are only observed in cardiac cells and they are lost upon Ldb1
deficiency. Recent studies analyzing enhancer contacts during
Drosophila development revealed that a large number of
enhancer interactions are unchanged between different tissues
and developmental stages and only few show significant
changes (Ghavi-Helm et al., 2014). Notably, Ldb1 appears to
mediate cell-type-specific chromatin loops and transcriptional
programs via its diverse DNAbinding partners (Figure 5, Figure 6,
and Figure 7; Soler et al., 2010; Song et al., 2007). Importantly,Cell Stem Cell 17, 287–299,Ldb1 deficiency led to dramatically
decreased expression of the genes associ-
ated with the AHF enhancer and overex-
pression of Isl1 and Ldb1 strongly
promoted their expression. The dosage-
sensitive interdependence between Isl1
and Ldb1 in the expression of these key fac-
tors in cardiogenesis further supports a key
role of the Isl1/Ldb1 complex in coordi-
nating genome organization and transcrip-
tional regulation upstream of a regulatory
network driving cardiac differentiation and
heart development.
In conclusion, our study highlights a
central role for Ldb1 in regulating cardiac
progenitor cell differentiation and SHF
development and provides exciting novel
insights into the molecular machinery thatorchestrates chromatin organization and coordinated gene
expression driving cardiogenesis.
EXPERIMENTAL PROCEDURES
A detailed description of the experimental procedures is provided in the Sup-
plemental Experimental Procedures.
Antibodies
The following primary antibodies were used: rabbit anti-HA (Y-11, Santa Cruz
Biotechnology), mouse anti-FLAG (M2, Sigma), goat anti-Ldb1 (N-18, Santa
Cruz Biotechnology), mouse anti-Ldb1 (C-9, Santa Cruz Biotechnology),
mouse anti-Islet1 39.4D5 (Developmental Studies Hybridoma Bank); goat
anti-Lamin B (C-20, Santa Cruz Biotechnology), mouse anti-tubulin (T5168,
Sigma), anti-GFP (ab6556, Abcam), APC-conjugated anti-Flk-1 (e-Biosci-
ence 17-5821-81), and PE-conjugated anti-PdgfR-a (e-Bioscience 12-
1401-81).
Immunoprecipitation and ChIP
Co-IPs and ChIP were performed as described in Witzel et al. (2012).September 3, 2015 ª2015 Elsevier Inc. 297
Chromosome Conformation Capture Assays: 3C-seq and 3C-qPCR
3C-seq and 3C-qPCR were performed as described in Stadhouders et al.
(2013). In brief, 107 cells or dissected SHF regions or tails of 20 E8–9 embryos
were crosslinked with 2% formaldehyde at room temperature for 10 min,
which was followed by glycine quenching; cell lysis; HindIII, NlaIII, or DpnII
digestion; and T4 ligation. Primer sequences used in the 3C assays are listed
in the Supplemental Experimental Procedures. r3Cseq, an R/Bioconductor
package, was used for the discovery of long-range genomic interactions in
the 3C-seq datasets (Thongjuea et al., 2013).
Zebrafish Strains
The following mutant and transgenic lines were used: Tg(myl7:EGFP-
HsHRAS)s883 (D’Amico et al., 2007) and isl1sa0029 (Sanger Institute, Zebrafish
Mutation Resource).
Mouse Lines
The Ldb1tm1a(EUCOMM)Hmgu line was generated from the microinjection of
Ldb1tm1a(EUCOMM)Hmgu ESCs, obtained from the European Conditional Mouse
Mutagenesis Program, into blastocysts. All animal experiments were done in
accordance with the regulations issued by the Committee for Animal Rights
Protection of the State of Hessen (Regierungspraesidium Darmstadt).
mRNA Injection
mRNA synthesis was performed using mMESSAGE mMACHINE SP6 Tran-
scription Kit (Ambion). mRNA was injected in the one-cell stage of fertilized
zebrafish eggs (volume, 2 nl; mRNA concentration, 200 ng/ml).
In Situ Hybridization, Whole-Mount Immunostaining, and Confocal
Microscopy
In situ hybridization and whole-mount staining were performed as described
(Witzel et al., 2012). Confocal images were acquired by a Zeiss LSM 710 sys-
tem and the Z-stacks were projected by Zeiss LSM 710 software.
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The accession number for the 3C-seq data reported in this paper is SRA:
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